Fasching PA, Hack CC, Nabieva N, Maass N, et al. Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole. Eur J Cancer 2024;209:114239.
PMID: 39059184